MoneyWorks4Me

Hikal informs about board meeting

24 Jan 2019 Evaluate

Pursuant to the provisions of Regulation 29 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Hikal has informed that the meeting of the Board of Directors of the company will be held on Friday, February 1, 2019 to consider, approve and to take on record the Standalone Unaudited Financial Results of the company for the quarter ended December 31, 2018 and to consider payment of interim dividend for the year 2018-19, if any.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..